HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria João Ramos Selected Research

TER 286 (TLK286)

11/2013Mechanism of glutathione transferase P1-1-catalyzed activation of the prodrug canfosfamide (TLK286, TELCYTA).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria João Ramos Research Topics

Disease

11Neoplasms (Cancer)
02/2021 - 01/2005
2Breast Neoplasms (Breast Cancer)
02/2021 - 11/2013
2Malaria
06/2004 - 07/2003
1Dermatitis
01/2022
1COVID-19
01/2022
1Virus Diseases (Viral Diseases)
01/2022
1Infertility (Sterility)
12/2019
1Parkinson Disease (Parkinson's Disease)
10/2017
1Hypercholesterolemia
11/2016
1Bacterial Infections (Bacterial Infection)
08/2014
1Heart Neoplasms
08/2014
1Alzheimer Disease (Alzheimer's Disease)
08/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2013
1Ovarian Neoplasms (Ovarian Cancer)
11/2013
1Acquired Immunodeficiency Syndrome (AIDS)
01/2009
1Inflammation (Inflammations)
01/2009
1Cataract (Cataracts)
08/2008
1Liver Cirrhosis (Hepatic Cirrhosis)
08/2008
1Hereditary Coproporphyria (Coproporphyrinogen Oxidase Deficiency)
03/2008
1Skin Diseases (Skin Disease)
03/2008
1HIV Infections (HIV Infection)
01/2008
1Dehydration (Water Stress)
03/2006
1Infections
04/2005

Drug/Important Bio-Agent (IBA)

8EnzymesIBA
05/2009 - 01/2005
2Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2009
2Aromatase (CYP19)IBA
02/2021 - 12/2019
2ZincIBA
08/2014 - 01/2008
2Farnesyltranstransferase (Farnesyltransferase)IBA
01/2008 - 01/2005
2Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
03/2006 - 01/2006
2Hemin (Panhematin)FDA Link
06/2004 - 07/2003
1Serine Proteases (Serine Protease)IBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1kojic acidIBA
01/2022
1Protein SIBA
01/2022
1SARS-CoV-2 spike proteinIBA
01/2022
1Monophenol Monooxygenase (Tyrosinase)IBA
01/2022
1pyromeconic acidIBA
01/2022
1Estrogen ReceptorsIBA
02/2021
1Selective Estrogen Receptor Modulators (SERM)IBA
02/2021
1TamoxifenFDA LinkGeneric
02/2021
1Aromatase InhibitorsIBA
02/2021
11,1- bis(4- hydroxyphenyl)- 2- phenylbut- 1- eneIBA
02/2021
1Fulvestrant (Faslodex)FDA Link
02/2021
1Estrogens (Estrogen)FDA Link
02/2021
1EndocannabinoidsIBA
12/2019
1Peptide Hydrolases (Proteases)FDA Link
10/2017
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2016
1Alkylating AgentsIBA
11/2013
1TER 286 (TLK286)IBA
11/2013
1Biological ProductsIBA
05/2009
1Transcription Factors (Transcription Factor)IBA
01/2009
1NF-kappa B (NF-kB)IBA
01/2009
1O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfateIBA
08/2008
1protoporphyrinogen (protoporphyrinogen IX)IBA
03/2008
1PropionatesIBA
03/2008
1Oxidoreductases (Dehydrogenase)IBA
03/2008
1Heme (Haem)IBA
03/2008
1coproporphyrinogen IIIIBA
03/2008
1Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
03/2008
1hydroxymethylbilaneIBA
03/2008
1geranylgeranyltransferase type-I (protein geranylgeranyltransferase)IBA
01/2008
1ras ProteinsIBA
01/2008
1Oxygen (Dioxygen)IBA
03/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2007
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
03/2007
1RibonucleotidesIBA
03/2006
1FlavonoidsIBA
07/2005
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
07/2005
1Drug Receptors (Drug Receptor)IBA
07/2003

Therapy/Procedure

2Drug Therapy (Chemotherapy)
11/2013 - 04/2005
2Therapeutics
03/2007 - 01/2006
1Highly Active Antiretroviral Therapy (HAART)
01/2008